Offering financial rewards to patients who lower their bad cholesterol by adhering to statin regimens could help prevent heart disease, but there are lingering questions about whether such a strategy is worth the added healthcare costs.
Paying People To Lower Their Cholesterol Works But Is It Cost-Effective?
